Science Explorer Interactive view Map
Company · Tokyo · Japan

Pfizer (Japan)

In research, Pfizer (Japan) stands highest in Medicine (#9,024 of 17,978 worldwide), Health Sciences (#11,910 of 20,462 worldwide) and Life Sciences (#10,956 of 14,347 worldwide), over all time.

pfizer.co.jp/pfizer/index.htmlROR OpenAlex
World rank, 2022–2025
#18,781
of 28,054 · #23,466 all time
Rank in Japan
#523
of 1,070
Research works
439
▲ 16% vs 2013–17
Citations
8k
18.1 per fractional work
Top-10% rate
18.2%
record average 16.5%
Open access
50%
world 28%

What is Pfizer (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #9,024 of 17,978 16.2%229
Health SciencesDomain #11,910 of 20,462 16.1%236
Life SciencesDomain #10,956 of 14,347 13.2%122

Each strip is that field’s whole ranked pool, with the notch where Pfizer (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.70× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 4.72× its world share, 4 worksImmunology and Micro…Neuroscience: 0.51× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 12.17× its world share, 3 worksPharmacology, Toxico…Chemistry: 0.49× its world share, 1 worksChemistryComputer Science: 0.26× its world share, 2 worksComputer ScienceEngineering: 0.05× its world share, 1 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMathematics: 1.92× its world share, 2 worksMathematicsHealth Professions: 0.69× its world share, 1 worksHealth ProfessionsMedicine: 3.21× its world share, 47 worksMedicineNursing: 0.45× its world share, 0 worksNursingArts and Humanities: 0.03× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.06× its world share, 0 worksBusiness, Management…Decision Sciences: 1.62× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.76× its world share, 4 worksEconomics, Econometr…Psychology: 0.56× its world share, 1 worksPsychologySocial Sciences: 0.09× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.2×. Every wedge is a field page.

Who are the top researchers at Pfizer (Japan)?

Ranked on the composite score, Yoko Fujimoto lead among researchers whose main affiliation is Pfizer (Japan).

  1. 1 Yoko Fujimoto Japan · #1,458,156 worldwide 9 citations · 21 works
All ranked researchers at Pfizer (Japan)

Which keywords describe research at Pfizer (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Clinical Trials, Breast Cancer, Inflammation, Diagnosis, Quality of Life, Pharmaceutical Industry and Treatment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology11▲ 3.8×43 topics
  2. Inflammation5▲ 3.1×19 topics
  3. Quality of Life4▲ 3.7×9 topics
  4. Clinical Trials4▲ 7.9×8 topics
  5. Treatment4▲ 4.0×16 topics
  6. Diagnosis4▲ 5.0×12 topics
  7. Breast Cancer3▲ 19×8 topics
  8. Pandemic3▲ 3.4×5 topics
  9. Clinical Practice Guidelines3▲ 6.6×7 topics
  10. Pharmaceutical Industry3▲ 94×2 topics
  11. Chemotherapy2▲ 4.8×10 topics
  12. Prophylaxis2▲ 25×2 topics
  13. Cost-effectiveness Analysis2▲ 35×1 topic
  14. Health Utility Measures2▲ 35×1 topic
  15. Autoantibodies2▲ 13×5 topics
  16. Guidelines2▲ 6.3×4 topics
  17. Cardiovascular Risk2▲ 8.8×3 topics
  18. Cytokines2▲ 9.6×2 topics
  19. Metastatic Breast Cancer2▲ 49×2 topics
  20. Pathogenesis2▲ 5.5×9 topics
  21. SARS-CoV-22▲ 8.5×4 topics
  22. Vaccine Development2▲ 11×4 topics
  23. Monoclonal Antibodies2▲ 29×3 topics
  24. Thrombosis2▲ 9.4×5 topics
  25. Adverse Drug Reactions2▲ 46×3 topics
  26. Antimicrobial Resistance2▲ 12×4 topics
  27. Recombinant Factor VIIa2▲ 56×2 topics
  28. Viral Infections2▲ 45×2 topics
  29. ACE2 Receptor2▲ 9.9×2 topics
  30. Anticoagulant Therapy2▲ 19×2 topics
  31. Efficacy2▲ 32×2 topics
  32. Gene Therapy2▲ 12×3 topics
  33. Human Metapneumovirus2▲ 53×1 topic
  34. Respiratory Syncytial Virus2▲ 53×1 topic
  35. Rheumatoid Arthritis2▲ 24×3 topics
  36. Biological Therapy2▲ 40×1 topic
  37. CDK4/6 Inhibitors2▲ 90×1 topic
  38. Disease-Modifying Antirheumatic Drugs2▲ 45×1 topic
  39. Mutation2▲ 12×3 topics
  40. Palbociclib2▲ 90×1 topic

Which research topics does Pfizer (Japan) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Respiratory viral infections research, Advanced Breast Cancer Therapies and Rheumatoid Arthritis Research and Therapies.

Health Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksRespiratory viral infect…2Respiratory viral infections research: 2 fractional worksAdvanced Breast Cancer Therapies: 2 fractional worksRheumatoid Arthritis Res…2Rheumatoid Arthritis Research and Therapies: 2 fractional worksPharmaceutical Economics…2Pharmaceutical Economics and Policy: 2 fractional worksHemophilia Treatment and Research: 2 fractional worksBiosimilars and Bioanalytical Methods: 2 fractional worksMigraine and Headache St…1Migraine and Headache Studies: 1 fractional worksAtrial Fibrillation Management and Outcomes: 1 fractional worksPneumonia and Respiratory Infections: 1 fractional works
Economics and EconometricsEpidemiologyPulmonary and Respiratory MedicineRheumatology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  2. 2 Respiratory viral infections research Epidemiology 2 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  4. 4 Rheumatoid Arthritis Research and Therapies Rheumatology 2 works
  5. 5 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
  6. 6 Hemophilia Treatment and Research Hematology 2 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 2 works
  8. 8 Migraine and Headache Studies Psychiatry and Mental health 1 works
  9. 9 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 1 works
  10. 10 Pneumonia and Respiratory Infections Epidemiology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.8%not open50.2%

World: 28% of research is openly available.

with international co-authors34.3%domestic only65.7%

World: 19% is written across borders.

How has Pfizer (Japan)'s research output changed?

Output in 2018–2022 was 16% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.